This site is intended for healthcare professionals only
LoginRegister
Shilpa Pharma Lifesciences Unit-1 successfully completes GMP inspection from Brazilian regulatory authorityShilpa Medicare arm gets 1 UFSDA observation for Raichur Unit
lupin acquires 3 anti diabetes trademarksLupin unveils heart drug Rivaroxaban in US
Pharma Firms To Face Periodic Inspection As HC Flags Effluent RisksCourt Restrains Medreich from Using Jubilant's Losartan, Amlodipine, Citalopram Dossiers
SEC Recommends Market Authorization for Elobixibat 5 mg Tablets by Exemed PharmaExemed Pharmaceutical Gets CDSCO Panel Nod To Manufacture Market Antidiabetic FDC
Unichem Labs Roha facility gets 3 USFDA observationsAlembic Pharma gets one procedural observation for Vadodara facility
Novartis eyes Avidity Biosciences in potential takeover: ReportNovartis Gets CDSCO Panel Nod To Study Antiparasitic drug LXE408
Axplora invests Euro 6.5 million to expand production capacity at Vizag siteLaurus Labs to invest Rs 83 crore in KRKA Pharma
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial MandatedEris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalJnJ to discontinue Phase 3 VENTURA development program evaluating aticaprant for major depressive...
AstraZeneca Imfinzi approved in EU as immunotherapy for limited stage small cell lung cancerCDSCO nod to AstraZeneca to import, sell hyperkalaemia treatment drug in India
Biocon Biologics, Civica join hands to expand Insulin Aspart access in USBiocon Biologics, Civica join hands to expand Insulin Aspart access in US
NPPA fixes retail prices of 53 formulations, DetailsNPPA fixes retail prices of 53 formulations, Details
X